| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 170.3K | - | - | |
| CEO | 82.9K | $6.00M | - | |
| Dir | 80.0K | - | - | |
| Dir | 59.6K | - | - | |
| Pres | 25.0K | $1.81M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | Brenda S. Furlow70 | SVP - General Counsel | Sale+OE | 3,538 | $473.95 | $1,676,849.37 | -31.7% | +3.9% | -25.2% | |
| Aug 9, 2021 | James Hippel74 | Chief Financial Officer | Sale+OE | 10,000 | $478.90 | $4,788,992.00 | -48.0% | +5.7% | -24.4% | |
| Jul 12, 2021 | James Hippel74 | Chief Financial Officer | Sale+OE | 10,000 | $456.67 | $4,566,663.21 | -52.3% | +6.0% | -21.6% | |
| Jun 18, 2021 | Charles R. Kummeth77 | Chief Executive Officer | Sell | 12,498 | $449.67 | $5,620,005.68 | -7.5% | +22.7% | -24.0% | |
| Jun 14, 2021 | Charles R. Kummeth77 | Chief Executive Officer | Sell | 7,481 | $449.15 | $3,360,066.10 | -4.3% | +11.9% | -27.6% | |
| Jun 9, 2021 | Kim Kelderman67 | President Diagnostics & Genom | Sell | 811 | $433.00 | $351,163.00 | -100% | +19.9% | -16.9% | |
| Jun 7, 2021 | James Hippel74 | Chief Financial Officer | Sale+OE | 9,942 | $421.93 | $4,194,831.17 | -52.1% | +22.6% | -12.5% | |
| May 25, 2021 | Kim Kelderman67 | President Diagnostics & Genom | Sell | 845 | $424.00 | $358,280.00 | -51.0% | +14.3% | -15.8% | |
| Feb 12, 2021 | Brenda S. Furlow70 | SVP - General Counsel | Sale+OE | 10,000 | $398.64 | $3,986,352.38 | -62.0% | - | - | |
| Feb 12, 2021 | James Hippel74 | Chief Financial Officer | Sale+OE | 10,000 | $400.39 | $4,003,908.16 | -52.3% | - | - |